Tivic Health Systems Inc (TIVC) Stock Price, Quote & News

Company Profile

Tivic Health Systems, Inc., a health tech company, develops and commercializes bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for use in the treatment of sinus pain, pressure, and congestion. The company sells its products through online retailers and commercial distributors, as well as its own website. Its lead product candidate is Entolimod, a late-stage TLR5 agonist for use in the treatment of acute radiation syndrome. In addition, the company markets its com...

Industry: Medical Devices

Sector: Healthcare

Phone: (888) 276-6888

Website: tivichealth.com

Address:

47685 Lakeview Blvd., Fremont, United States

SwingTradingPro Sep. 9 at 4:08 AM

$TIVC primed for a bullish run very soon.. keep loading and holding... Low float .. 12$ PT

0 · Reply

petertradebull Sep. 4 at 12:32 PM

$TIVC waiting for the FDA approval and gov contracts 🚀🚀🚀

1 · Reply

petertradebull Sep. 1 at 3:48 PM

$TIVC very very bullish 🚀🚀🚀

0 · Reply

Espre Aug. 29 at 2:47 PM

$TIVC https://m.economictimes.com/news/international/us/russia-nuclear-test-putin-poised-for-first-nuclear-bomb-tests-in-35-years-at-arctic-site-ukraine-war-latest-news/articleshow/123563364.cms

1 · Reply

Espre Aug. 29 at 2:29 PM

$TIVC From what I’ve gathered, Entolimod over current alternatives is a no brainer, especially if it’s viable for the stockpile program. Big question now is how much dilution will be needed to make it a reality, and if production development-news will offset dilution-news. If they get non-dilutive financing, which has happened in the past for similar products, I think we’re looking at a 10 bagger at least, maybe more? Thoughts?

1 · Reply

AceLiu92 Aug. 28 at 4:49 PM

$TIVC Get in when its low

0 · Reply

ExecutiveEdge Aug. 28 at 12:59 PM

TGL is about to flip the script. Tiny float, big treasury, PR machine loaded. This is how parabolas begin. $ALZN $RCEL $LEXX $TIVC

1 · Reply

petertradebull Aug. 28 at 12:10 AM

$TIVC matter of time 🚀🚀🚀

0 · Reply

scottcod Aug. 27 at 6:28 PM

$TIVC What is this stock doing 🤯

1 · Reply

TheOpticZone Aug. 27 at 12:20 PM

$TIVC Unfortunately not the share price

1 · Reply

Tivic Receives Two Investigational New Drug Applications for Entolimod™ for the Treatment of Acute Radiation Syndrome (ARS) and Advanced Cancers

Aug 15, 2025, 8:30 AM EDT - 25 days ago

Tivic Health Advances Discussions on Use of Entolimod as a Radiation Countermeasure at Military Health System Research Symposium 2025

Aug 14, 2025, 7:59 PM EDT - 25 days ago

Tivic Health Systems, Inc. (TIVC) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 4:00 PM EDT - 25 days ago

Tivic Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 8:30 AM EDT - 4 weeks ago

Tivic Health to Report Second Quarter 2025 Financial Results on August 14th Via Conference Call and Webcast

Jul 8, 2025, 8:30 AM EDT - 2 months ago

Tivic Shareholders Approve Key Proposals in Support of Strategic Transformation; Lisa Wolf Appointed Permanent CFO

Jun 25, 2025, 8:30 AM EDT - 2 months ago

Tivic Health Completes Optimization Study for Its Non-Invasive Vagus Nerve Stimulation Device

Jun 24, 2025, 8:30 AM EDT - 2 months ago

Tivic Health Announces 2025 Annual Meeting of Stockholders

May 15, 2025, 9:11 PM EDT - 4 months ago

Tivic Health Systems Inc. (TIVC) Q1 2025 Earnings Call Transcript

May 15, 2025, 4:05 PM EDT - 4 months ago

Tivic Reports First Quarter 2025 Financial Results and Provides Updates on Business Transformation

May 14, 2025, 8:30 AM EDT - 4 months ago

Tivic Health Enters GMP Manufacturing Validation Agreement with Scorpius BioManufacturing in Preparation for FDA Submission

May 13, 2025, 8:30 AM EDT - 4 months ago

Tivic Expands VNS Intellectual Property Portfolio

May 9, 2025, 8:30 AM EDT - 4 months ago

Tivic Health to Report First Quarter 2025 Financial Results on May 15th Via Conference Call and Webcast

Apr 22, 2025, 8:30 AM EDT - 5 months ago

Tivic Health Reports White House Briefing and FDA Meetings Secured Positive Interest in Potential Military and Defense Applications of Its Product Candidates

Apr 15, 2025, 8:30 AM EDT - 5 months ago

Tivic Health Extends its Worldwide License of TLR5 Agonist Entolimod to Include the Treatment of Neutropenia

Apr 10, 2025, 8:30 AM EDT - 5 months ago

Tivic Health Systems, Inc. Regains Compliance with NASDAQ Minimum Bid Price Listing Rule

Mar 21, 2025, 6:32 PM EDT - 6 months ago

Tivic Health Systems, Inc. (TIVC) Q4 2024 Earnings Call Transcript

Mar 21, 2025, 4:00 PM EDT - 6 months ago

Tivic Reports Year End 2024 Financial Results and Provides Overview of Strategy for Transformation and Growth

Mar 13, 2025, 4:59 PM EDT - 6 months ago

Tivic Health to Report 2024 Year-End Financial Results on March 21st Via Conference Call and Webcast

Mar 6, 2025, 8:15 AM EST - 6 months ago

Tivic Health and Feinstein Institute Present New Data Showing Personalized Vagus Nerve Stimulation Method Optimizes Impact on Autonomic Nervous System

Mar 5, 2025, 8:15 AM EST - 6 months ago

Tivic Health Systems, Inc. Announces Reverse Stock Split

Mar 3, 2025, 8:15 AM EST - 6 months ago

Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve

Feb 24, 2025, 8:15 AM EST - 7 months ago

Tivic Health Names Biotech Industry Veteran Michael K. Handley to Executive Leadership Team

Feb 12, 2025, 8:30 AM EST - 7 months ago

Tivic Health Acquires Exclusive Worldwide Rights to Phase III TLR5 Agonist from Statera Biopharma

Dec 23, 2024, 4:54 PM EST - 9 months ago

CEO Letter to Shareholders Issued by Tivic Health

Nov 14, 2024, 11:36 PM EST - 10 months ago

Tivic Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 14, 2024, 6:20 PM EST - 10 months ago

Tivic Health Systems, Inc. (TIVC) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 8:45 AM EST - 10 months ago

Enrollment Complete in Tivic Health Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device

Nov 12, 2024, 8:30 AM EST - 10 months ago

Tivic Health Validates European Patents in Great Britain, Germany, and France

Nov 7, 2024, 8:30 AM EST - 10 months ago

Tivic Health Systems, Inc. to Report Third Quarter 2024 Financial Results on November 14

Oct 29, 2024, 8:00 AM EDT - 11 months ago

First Subject Enrolled in Tivic Health's Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device

Oct 24, 2024, 8:30 AM EDT - 11 months ago

Tivic Health CEO Jennifer Ernst to Present at New York BioFuture 2024

Sep 18, 2024, 9:00 AM EDT - 1 year ago

Tivic Health Receives Approval from Institutional Review Board for ncVNS Optimization Study, Readies for Enrollment

Sep 17, 2024, 9:00 AM EDT - 1 year ago

Tivic Health Accelerates VNS Commercial Strategy Development

Sep 13, 2024, 5:29 PM EDT - 1 year ago

Tivic Health Appoints Lisa Wolf as Interim Chief Financial Officer

Aug 15, 2024, 3:25 AM EDT - 1 year ago

Tivic Health Systems, Inc. (TIVC) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:15 PM EDT - 1 year ago

Tivic Reports Second Quarter 2024 Financial Results

Aug 6, 2024, 9:15 AM EDT - 1 year ago

Tivic Health to Report Q2 2024 Financial Results and Corporate Update on August 14th Via Conference Call and Webcast

Aug 6, 2024, 9:00 AM EDT - 1 year ago

ASM Global Continues Its Live Programming Growth Naming Industry Veteran Ralph Marchetta as Regional Vice President of Live Entertainment

Aug 2, 2024, 9:15 AM EDT - 1 year ago

Tivic Announces 2024 Annual Meeting of Stockholders

Jul 23, 2024, 10:00 AM EDT - 1 year ago

Tivic Health Expands Intellectual Property Portfolio

Jun 18, 2024, 9:15 AM EDT - 1 year ago

Tivic Health: Christina Valauri Appointed to Board of Directors

Jun 18, 2024, 9:00 AM EDT - 1 year ago

ServiceNow debuts as a Leader in P&C Claims Management Systems report by independent research firm

NSYS

May 22, 2024, 9:00 AM EDT - 1 year ago

Tivic Health Partners with the Feinstein Institutes to Advance its Patent-pending, Non-Invasive Cervical Vagus Nerve Stimulation; Begins Optimization of ncVNS for use in Clinical Indications

May 15, 2024, 8:26 PM EDT - 1 year ago

Tivic Health Systems, Inc. (TIVC) Q1 2024 Earnings Call Transcript

May 15, 2024, 4:26 PM EDT - 1 year ago

Tivic Reports First Quarter 2024 Financial Results and Subsequent Events

May 13, 2024, 5:11 PM EDT - 1 year ago

Tivic Health to Report Q1 2024 Financial Results and Subsequent Events on May 15th Via Conference Call and Webcast

May 13, 2024, 4:30 PM EDT - 1 year ago

Tivic Health Announces Closing of $4.0 Million Public Offering

May 9, 2024, 9:20 AM EDT - 1 year ago

Tivic Health Announces Pricing of $4.0 Million Public Offering

May 8, 2024, 9:00 AM EDT - 1 year ago

Tivic Health Announces Successful Completion of Non-Invasive Vagus Nerve Stimulation Study (VNS); Demonstrates Clinically Effective Biological Changes in the Autonomic, Cardiac, and Central Nervous Systems

SwingTradingPro Sep. 9 at 4:08 AM

$TIVC primed for a bullish run very soon.. keep loading and holding... Low float .. 12$ PT

0 · Reply

petertradebull Sep. 4 at 12:32 PM

$TIVC waiting for the FDA approval and gov contracts 🚀🚀🚀

1 · Reply

petertradebull Sep. 1 at 3:48 PM

$TIVC very very bullish 🚀🚀🚀

0 · Reply

Espre Aug. 29 at 2:47 PM

$TIVC https://m.economictimes.com/news/international/us/russia-nuclear-test-putin-poised-for-first-nuclear-bomb-tests-in-35-years-at-arctic-site-ukraine-war-latest-news/articleshow/123563364.cms

1 · Reply

Espre Aug. 29 at 2:29 PM

1 · Reply

AceLiu92 Aug. 28 at 4:49 PM

$TIVC Get in when its low

0 · Reply

ExecutiveEdge Aug. 28 at 12:59 PM

TGL is about to flip the script. Tiny float, big treasury, PR machine loaded. This is how parabolas begin. $ALZN $RCEL $LEXX $TIVC

1 · Reply

petertradebull Aug. 28 at 12:10 AM

$TIVC matter of time 🚀🚀🚀

0 · Reply

scottcod Aug. 27 at 6:28 PM

$TIVC What is this stock doing 🤯

1 · Reply

TheOpticZone Aug. 27 at 12:20 PM

$TIVC Unfortunately not the share price

1 · Reply

petertradebull Aug. 26 at 9:22 PM

$TIVC very very bullish 🚀🚀🚀

0 · Reply

TheOpticZone Aug. 26 at 5:02 PM

$TIVC I guess it is going to be a long wait to move up.

0 · Reply

StardustNdreams Aug. 25 at 11:05 PM

$TIVC Five days ago- https://www.businesswire.com/news/home/20250820053049/en/Tivic-Receives-Two-Investigational-New-Drug-Applications-for-Entolimod-for-the-Treatment-of-Acute-Radiation-Syndrome-ARS-and-Advanced-Cancers One week ago- https://www.businesswire.com/news/home/20250815269899/en/Tivic-Health-Advances-Discussions-on-Use-of-Entolimod-as-a-Radiation-Countermeasure-at-Military-Health-System-Research-Symposium-2025

1 · Reply

StardustNdreams Aug. 25 at 10:52 PM

$TIVC

0 · Reply

StardustNdreams Aug. 25 at 10:21 PM

$TIVC still continuing to add here

0 · Reply

SwingTradingPro Aug. 25 at 4:16 PM

$TIVC this stock will make few of us here very rich very soon..

0 · Reply

TheOpticZone Aug. 25 at 1:58 AM

$TIVC need a lot more than that!

0 · Reply

Halo202 Aug. 24 at 11:04 PM

$TIVC $3.30+ this week

0 · Reply

Espre Aug. 24 at 2:41 PM

$TIVC -far superior efficacy data compared to alternatives -US prioritizing to onshore production of critical supplies and technology -strategic benefit to having options in supply chain or simple path to transition to a superior product -volatile geopolitical landscape and tensions -ongoing and continual stockpile program -military budgets increasing across the globe It’s a pretty strong case and I’m surprised we’re not seeing more traction. Unless there’s some indication or evidence of a superior product currently in the pipeline? that could be available in the near future. Otherwise I struggle to see a reason why they would allow TIVC to fail. Maybe if it does not meet requirements for shelf-life or cost per unit is high, but I assume it’ll be on par with current alternatives. I do however agree that a unproven track record is relevant and a big factor, but with prospects and possibilities like this, the stock seems undervalued. Thoughts? Am I missing something?

0 · Reply

DeepValueFinders Aug. 22 at 7:44 PM

$TIVC Didn’t call it.

0 · Reply

StardustNdreams Aug. 22 at 11:15 AM

$TIVC https://www.businesswire.com/news/home/20250815269899/en/Tivic-Health-Advances-Discussions-on-Use-of-Entolimod-as-a-Radiation-Countermeasure-at-Military-Health-System-Research-Symposium-2025

0 · Reply

Espre Aug. 22 at 10:12 AM

$TIVC how likely do we think that they will get non-dilutive financing? (BARDA)

1 · Reply

Market Cap	3.18M
Revenue (ttm)	780,000.00
Net Income (ttm)	-5.66M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-725.64%
Debt to Equity Ratio	0.00

Volume	35,900
Avg Vol	1,240,432
Day's Range	N/A - N/A
Shares Out	1.08M
Stochastic %K	18%
Beta	1.97
Analysts	Strong Buy
Price Target	N/A